feed,title,long_url,short_url
SeekingAlpha,VYNE Therapeutics falls 13% after BET inhibitor licensing deal with In4derm,https://seekingalpha.com/news/3729513,
SeekingAlpha,On the hour,https://seekingalpha.com/news/3729512,
SeekingAlpha,Organon posts quarterly revenue growth driven by Womenâ€™s Health,https://seekingalpha.com/news/3729511,
SeekingAlpha,Builders FirstSource announces $1B in stock repurchase plan,https://seekingalpha.com/news/3729510,
SeekingAlpha,"Xebec Adsorption EPS misses by $0.04, beats on revenue",https://seekingalpha.com/news/3729509,
SeekingAlpha,Southwest Airlines is the top U.S. airline pick at Morgan Stanley,https://seekingalpha.com/news/3729508,
SeekingAlpha,Adagene names Steven Fischkoff interim Chief Medical Officer,https://seekingalpha.com/news/3729507,
SeekingAlpha,Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity,https://seekingalpha.com/article/4446724,
SeekingAlpha,Flex LNG: Surging Cash Flows And Dividends (Podcast Transcript),https://seekingalpha.com/article/4447846,
SeekingAlpha,AOA Vs. EAOA: Comparing The Standard And ESG Versions Of These iShares ETFs,https://seekingalpha.com/article/4447599,
SeekingAlpha,NUSI: Fun With Benchmarks,https://seekingalpha.com/article/4448468,
SeekingAlpha,VIZIO: Assessing The Expectations Already Priced In,https://seekingalpha.com/article/4448509,
